Industry News Archives | Page 6 of 21

PHARMA CASH ROLLS INTO CONGRESS TO DEFEND AN EMBATTLED INDUSTRY

By Emmarie Huetteman, Jay Hancock and Elizabeth Lucas In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor. In…

RA MEDICAL SYSTEMS RECEIVES NYSE NOTICE RELATED TO DELAY IN FORM 10-Q FILING

Ra Medical Systems, Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, has announced that it received a notice from the NYSE indicating that Ra Medical is not in compliance with…

BACKLOG OF VA HEALTH RECORD DIGITIZATION WOULD STACK 5 MILES HIGH

Despite the Veterans Health Administration reporting in July that they have transferred 23.5 million health records, covering some 78 billion data points, from the VA EHR to a shared data center with the DOD, if every single one of the…

PAYER ANALYSIS: ‘CADILLAC TAX’ ON HIGH-COST HEALTH PLANS COULD AFFECT 1 IN 5 EMPLOYERS IN 2022

[/infobox][infobox title=’CADILLAC TAX ANALYSIS’]An Analysis by the Kaiser Family Foundation[/infobox] A new KFF analysis estimates that the Affordable Care Act’s tax on high-cost health plans would affect one in five (21 percent) employers offering health benefits when it takes effect in…

June262019October252024

CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES

Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair…

June262019October252024

ABBVIE ACQUIRING ALLERGAN AS HEDGE AGAINST EXPIRATION OF HUMIRA PATENT

As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock. Humira sales account for more than 60…

FUZZY MATH: Sanders’ Claim That Cost Barriers To HealthCare Kill 30,000 A Year IS only half true

TWEET “30,000 Americans a year die waiting for health care because of the cost.” –Sen. Bernie Sanders (I-Vt.), in a tweet June 20 By Shefali Luthra “Medicare for All” — or single-payer health care — is a flagship issue…

RATIONAL SUICIDE: Seniors want to call it quits on own schedule

(Caitlin Hillyard/KHN) By Melissa Bailey Ten residents slipped away from their retirement community one Sunday afternoon for a covert meeting in a grocery store cafe. They aimed to answer a taboo question: When they feel they have lived long enough,…

VSA, PRACTICE MANAGEMENT FIRM, OBSERVES 17TH YEAR

Vein Centers of America (VSA) is celebrating its 17th anniversary by offering a complimentary phone consultation with President and CEO David Schmiege. in vein-specific practice management, marketing and revenue cycle management initiatives nationwide. “We have the experience, flexibility, structure…

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes…